ANBENITAMAB

UNII:	RHS90QRF9E
Formula:
Preferred Substance Name:	ANBENITAMAB
GSRS Full Record:	RHS90QRF9E i

2367012-88-0
ANBENITAMAB [INN]
ANTI-HER2 BSAB KN026
IMMUNOGLOBULIN G1 (369-SERINE,371-ALANINE,408-LYSINE,410-VALINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2 DOMAIN IV)(HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 4D5 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 4D5 .KAPPA.-CHAIN, (229->228'),(232->231')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (368-TRYPTOPHAN,411-ALANINE) ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2 DOMAIN II)(HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 2C4 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 4D5 .KAPPA.-CHAIN
KN 026 [WHO-DD]
KN026
KN-026

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ANBENITAMAB

Synonyms and Mappings

Resources